Fidelity Nordic Fund OCSE:NSIS B Holdings History
Number of Shares
73,500.00
Current Holdings Value*
kr4.75 Mil
% of Portfolio
1.59%
Total Estimate Gain
kr2.34 Mil
% of Total Estimate Gain
7.81%
Fidelity Nordic Fund's Novonesis (Novozymes) B Holding Summary
As of 2025-04-30, FIDELITY INVESTMENT TRUST held 73,500.00 shares of Novonesis (Novozymes) B(OCSE:NSIS B), totaling kr4.75 Mil. This investment constitutes 1.59% of their stock portfolio, and FIDELITY INVESTMENT TRUST now holds 0.02% of the outstanding Novonesis (Novozymes) B(OCSE:NSIS B) stock.
The initial trade took place in 2025Q2. And since then Fidelity Nordic Fund has made 1 purchases of OCSE:NSIS B, at an average price of kr408.03, for a total of 73,500.00 shares. Based on historical transaction data and OCSE:NSIS B's current price of kr439.90, Fidelity Nordic Fund's estimated gain on his OCSE:NSIS B holdings is kr2.34 Mil, reflecting a 7.81% gain to date.
Fidelity Nordic Fund OCSE:NSIS B (kr439.90) Holding Chart
Fidelity Nordic Fund OCSE:NSIS B (kr439.90) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price kr-/Share | ||
Shares Sold | 0 | Average Price kr-/Share | ||
Current Price kr0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1